Stock Trading History of Bowman Jack L
The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider
Bowman Jack L since year 2005.
The trader's CIK number is
1014094.
At the time of this reporting, Bowman Jack L is the Director of
Celgene Corp /de/
(stock ticker symbol
CELG).
Note that in the past
BOWMAN JACK L also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by Bowman Jack L since 2005.
| Trade Date |
Symbol |
Company Name (Issuer) |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2007-05-07 | CELG | Celgene Corp /de/ | Option Exercise | 40,000 | 8.40 | 336,200 |
| 2007-05-07 | CELG | Celgene Corp /de/ | Sale | 40,000 | 62.76 | 2,510,384 |
| 2007-02-09 | CELG | Celgene Corp /de/ | Sale | 40,000 | 55.66 | 2,226,248 |
| 2007-02-09 | CELG | Celgene Corp /de/ | Option Exercise | 40,000 | 8.40 | 336,200 |
| 2006-10-30 | CELG | Celgene Corp /de/ | Option Exercise | 40,000 | 7.70 | 308,100 |
| 2006-10-30 | CELG | Celgene Corp /de/ | Sale | 40,000 | 49.42 | 1,976,720 |
| 2006-07-31 | CELG | Celgene Corp /de/ | Option Exercise | 40,000 | 4.41 | 176,500 |
| 2006-07-31 | CELG | Celgene Corp /de/ | Sale | 40,000 | 47.57 | 1,902,863 |
| 2006-05-01 | CELG | Celgene Corp /de/ | Option Exercise | 40,000 | 1.30 | 52,084 |
| 2006-05-01 | CELG | Celgene Corp /de/ | Sale | 40,000 | 41.94 | 1,677,592 |
| 2006-03-17 | AVII | Avi Biopharma Inc | Purchase | 5,000 | 6.36 | 31,800 |
| 2006-02-02 | CELG | Celgene Corp /de/ | Option Exercise | 20,000 | 2.60 | 52,080 |
| 2006-02-02 | CELG | Celgene Corp /de/ | Sale | 20,000 | 70.69 | 1,413,760 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bowman Jack L
(Director of Celgene Corp /de/ at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
